Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study.
- DOI
- 10.1136/bmjno-2021-000203
- Published
- 2022
- Container
- BMJ neurology open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjno-2021-000203,
title = {Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study.},
author = {Raghavan K and Dedeepiya VD and Ikewaki N and Sonoda T and Iwasaki M and Preethy S and Abraham SJ},
year = {2022},
journal = {BMJ neurology open},
doi = {10.1136/bmjno-2021-000203},
url = {https://doi.org/10.1136/bmjno-2021-000203}
}RIS
TY - JOUR TI - Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study. AU - Raghavan K AU - Dedeepiya VD AU - Ikewaki N AU - Sonoda T AU - Iwasaki M AU - Preethy S AU - Abraham SJ PY - 2022 JO - BMJ neurology open DO - 10.1136/bmjno-2021-000203 UR - https://doi.org/10.1136/bmjno-2021-000203 ER -
APA
K, R., VD, D., N, I., T, S., M, I., S, P., & SJ, A. (2022). Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study.. BMJ neurology open. https://doi.org/10.1136/bmjno-2021-000203
Source records
- pubmed · retrieved 2026-09-26T10:43:19.580Z